You Might Like

Novavax COVID jab manufacturer reveals £400m Teesside plant expansion The company slated to manufacture tens of millions of Novavax coronavirus vaccines at its plant on Teesside has announced a £400m expansion plan for the site. Sky News - Published on December 1, 2021

New variant may force drug companies to tweak Covid vaccination plans The emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday.. IndiaTimes - Published on November 29, 2021

Govt panel seeks additional data from SII, says Covovax not yet been approved in country of origin IndiaTimes - Published on November 28, 2021

Novavax files for emergency use listing of Covid-19 vaccine with WHO IndiaTimes - Published on November 5, 2021

Novavax Covid-19 vaccine receives first emergency use authorization Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for.. IndiaTimes - Published on November 1, 2021

SII now aims to include kids aged 2 to 6 in vaccination trials in a month The Serum Institute of India has expanded Covovax’s paediatric trial in seven to 11 years age bracket across 10 sites in India, including Pune, after ensuring vaccine safety in adolescents. The.. IndiaTimes - Published on October 5, 2021

Recruitment of volunteers for trial of Covid vaccine Covovax on children begins IndiaTimes - Published on August 29, 2021

Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO Adar Poonawalla IndiaTimes - Published on August 6, 2021

Govt panel recommends against allowing SII to conduct trial of Covovax on children aged 2-17 yrs An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine.. IndiaTimes - Published on July 1, 2021

Serum Institute's COVID-19 vaccine 'Covovax' likely to launch by September The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax. DNA - Published on June 17, 2021

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries. DNA - Published on June 15, 2021

Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum.. IndiaTimes - Published on June 14, 2021

Novavax COVID jab 100% effective in protecting against moderate and severe disease, trial suggests Novavax has said its COVID-19 vaccine is 100% effective in protecting against "moderate and severe disease" following its phase three trial results. Sky News - Published on June 14, 2021